Stay updated with breaking news from Five Prime. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
"NK Cell Therapy Clinical Trials"(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, NK Cell Therapy pipeline constitutes 100+ key companies continuously working towards developing
Wang, who joins Harpoon from Hummingbird Bioscience, has a background of 15 years in biopharma business development and finance.
January 2023 Developing next-generation immunotherapies that address cancer immune resistance KA Disclaimers and other information Cautionary... | January 5, 2023
Amgen’s drug portfolio boasts several biologic drugs that are blockbuster sellers. In acquiring ChemoCentryx for $3.7 billion, the pharmaceutical giant gains a company entirely focused on developing small molecule alternatives to biologic medicines.
MRVI earnings call for the period ending June 30, 2022.